Ian Smith work email
- Valid
Ian Smith personal email
Ian Smith is a CEO at Aston Particle Technologies Ltd.. He possess expertise in technology transfer, drug delivery, r&d, product development, medical devices and 16 more skills.
Aston Particle Technologies Ltd.
View- Website:
- astonparticletechnologies.com
- Employees:
- 11
-
CeoAston Particle Technologies Ltd.Potton, Gb
-
ChairmanAston Particle Technologies Ltd. Feb 2018 - PresentBirmingham, United Kingdom
-
CeoAston Particle Technologies Ltd. Apr 2016 - PresentBirmingham, United KingdomAston Particle Technologies is developing a radical and highly efficient method of coating substrate particles in the aerosolised state rather than by traditional solid phase processes.
-
Founder And DirectorH12 Consulting Apr 2010 - PresentCambridge UkIndustry consultant in respiratory product developments, drug delivery device development, and technical business plan developments and evaluation
-
Non Executive DirectorGlidepharma Mar 2013 - Sep 2017 -
CeoGlidepharma Dec 2011 - Mar 2013Oxford, United KingdomRaised £14 million with Invesco Asset Management as the lead investor.Glide is a UK based company focused on the development and commercialisation of a simple mechanical system for the safe and convenient injection of solid dose formulations of drugs and vaccines.
-
Healthcare Advisory Board MemberNypro May 2011 - Sep 2014Clinton, MaNypro is a world leader in the design and manufacture of high quality drug delivery and medical devices. -
Head Of Inhalation And Devices Centre Of EmphasisPfizer Research And Development Nov 2004 - Apr 2010SandwichExecutive Director with staff located in Sandwich and Cambridge, UKGlobal responsibility for inhaled product developments including device and product manufacturing processes Global responsibility for all classes of device development – inhaled, injector, ocular, nasal and othersMember of the company’s Respiratory Medicines Management Team
-
Founder And Chief Executive OfficerMeridica Ltd May 2001 - Nov 2004Melbourn UkDrug delivery company focussing on inhaler device development acquired by Pfizer in November 2004Created and developed a novel DPI with performance and patient acceptance beyond the current market leaderCompany valuation of $140 million on the acquisition of Meridica by Pfizer Inc from a total investment of circa $10 million (£5.5 million)
-
PartnerPa Consulting Group Jun 1997 - May 2001Melbourn UkHead of Medical Devices Development Group and Member of the Technology Division BoardStrategic, technology and drug device based consulting to major global pharmaceutical (Novartis, Schering AG, Pfizer Inc) and biotechnology companies (Alkermes, SkyePharma, Weston Medical)PA Consulting Group Lead for a Joint Venture with SkyePharma for MDI device programmeTechnical due diligence for several company and technology acquisitions including LSE listings -
Research DirectorAndaris Ltd Aug 1995 - Jun 1997Nottingham UkRationalised R&D from 12 to 4 programmes with an increase in staff and clear focus on value-adding developmentsChanged company culture to project a professional approach to R&D and its commercial exploitationEstablished contemporary R&D systems to provided sound basis for subsequent company acquisition
-
Head, Inhalation Product Development And Pharmaceutical TechnologyGlaxo Nov 1983 - Jul 1995Ware UkLead a team of circa 100 scientists and engineers responsible for inhaled product and device based developmentsLeader of company-wide drug product development project teams Developed current market leading DPI device (Diskus) and the drug products, Imigran intranasal and auto-injector products, paediatric inhaled drug delivery spacer, and their associated manufacturing processes Member of the company’s Respiratory Product Development Committee Member of a United Nations Committee charged with the global phase out of CFCs from aerosol products (1989 – 1994)
-
Research ManagerUnilever May 1974 - Nov 1983Port Sunlight, Wirral UkNumerous research roles including; detergents for emerging markets, non-aggressive hand and body soaps, and enhanced technology transfer processes and information science / technology evaluation -
Post Doctoral Research FellowUniversity Of Liverpool Oct 1972 - May 1974Liverpool UkBasic research in the field of cross-linked hydrophilic polymer matrices as potential vehicles for de-salination
Ian Smith Skills
Ian Smith Education Details
-
University Of AstonChemistry -
University Of AstonChemistry
Frequently Asked Questions about Ian Smith
What company does Ian Smith work for?
Ian Smith works for Aston Particle Technologies Ltd.
What is Ian Smith's role at the current company?
Ian Smith's current role is CEO.
What is Ian Smith's email address?
Ian Smith's email address is ia****@****net.com
What schools did Ian Smith attend?
Ian Smith attended University Of Aston, University Of Aston.
What skills is Ian Smith known for?
Ian Smith has skills like Technology Transfer, Drug Delivery, R&d, Product Development, Medical Devices, Pharmaceutical Industry, Formulation, Biotechnology, Pharmaceutics, Drug Development, Regulatory Affairs, Commercialization.
Who are Ian Smith's colleagues?
Ian Smith's colleagues are David Wyatt, Rhys Jones, Jasdip Koner.
Not the Ian Smith you were looking for?
-
1slayer.com
-
3namshi.com, hotmail.com, urbanoutfitters.com
4 +442032XXXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial